Brown, Lisle/Cummings, Inc. Ark Genomic Revolution ETF (De Transaction History

Brown, Lisle/Cummings, Inc.

  • $294 Billion
  • Q1 2024

A detailed history of Brown, Lisle/Cummings, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 250 shares of ARKG stock, worth $5,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$5,810
Previous $8.2 Million 12.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 28, 2024
BUY
$27.46 - $36.49 $2,059 - $2,736
75 Added 42.86%
250 $7.52 Million
Q4 2022

Jun 28, 2024
BUY
$27.08 - $36.23 $2,030 - $2,717
75 Added 75.0%
175 $4.94 Million
Q1 2022

Jun 28, 2024
BUY
$38.15 - $63.26 $3,815 - $6,326
100 New
100 $4.59 Million

Others Institutions Holding ARKG

# of Institutions
317
Shares Held
19.1M
Call Options Held
1.49M
Put Options Held
2.83M
View Full List

About ARK GENOMIC REVOLUTION ETF (DE

ARKG Quotes by TradingView
  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email